GSK's acquisition of Chimagen Biosciences enhances its autoimmune portfolio with CMG1A46, a promising therapy for lupus, expanding treatment options and innovation.
FDA approves Opdivo with chemotherapy for resectable NSCLC, enhancing survival rates. Learn about the CheckMate-77T trial and Bristol Myers Squibb's efforts.
AI investment is crucial for Europe's innovation and competitiveness. Explore Nvidia's role, strategic infrastructure like the Gefion Supercomputer, and economic benefits.
Tesla shares hit a 13-month high post-earnings, driven by market confidence and innovation. Explore the factors behind this surge and future implications.
European stocks slip at open; Mercedes down 3.2% after earnings plummet. Explore market volatility, investment strategies, and growth opportunities.
Executive Summary Global equity markets have experienced significant growth from 2020 to 2024, with major indices such as the DAX30, Nikkei 225, S&P 500, and STOXX 600 showing strong...
Clesrovimab shows promise in reducing infant RSV hospitalizations. Learn about Merck's trial results and future plans for this innovative monoclonal antibody.
Immusoft's ISP-001 B cell therapy offers a new hope for rare genetic disorders, showcasing safety, efficacy, and potential to transform treatment paradigms.
Explore 2024's enterprise tech trends: AI, cloud, cybersecurity, IoT, and data analytics. Stay ahead with strategic tech investments and innovation.
Pfizer's Phase 3 trial of gene therapy for Duchenne muscular dystrophy shows no significant results. Future research will be supported by detailed data.